Bill Gates is getting help from some fellow billionaire philanthropists as he and other health leaders work to overcome setbacks that have delayed the eradication of polio despite a recent sharp decline in the number of cases.
Our modern way of life is a major cause of many noncommunicable diseases (NCDs). Initially lifestyle diseases of industrialized countries, they have long since reached developing countries and lead to serious consequences and tremendous costs for health care systems worldwide. Above all, the implementation of sustainable solutions calls for political action.
Mike Bloomberg Co-Hosts a Twitter Chat on WHO's Work to Reduce Noncommunicable Diseases - 10AM, Thursday 8/25/2016.
Mike Bloomberg co-hosted a #BeatNCDs Twitter chat with the WHO's Dr. Etienne Krug, answering questions on his recent appointment as the WHO Global Ambassador for Noncommunicable Diseases and the organization's expanding effort to reduce preventable death and injury from NCDs worldwide.
- Building on the company's successful history in developing vaccines against similar viruses, most recently the introduction of Dengvaxia® against dengue, Sanofi Pasteur is launching a Zika vaccine project -
LYON, France, March 10, 2016 /3BL Media/ - Sanofi Pasteur, the vaccines division of Sanofi, announced today that it has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.
GAITHERSBURG, Md., October 29, 2015 /3BL Media/ - Sodexo, a leading provider of integrated facilities management and food service operations, announced a partnership today with SureWash, maker of a mobile, automated, interactive hand hygiene training and assessment system.
U.S. Patent and Trademark Office Honors Sanofi for its Anti-Malarial Treatment
BRIDGEWATER, NJ, April 15, 2015 /3BL Media/ – Sanofi announced today that the U.S. Commerce Department’s United States Patent and Trademark Office (USPTO) named the company one of 10 recipients of its prestigious “Patent for Humanity” award. Sanofi is being recognized for its patent that covers an innovative chemical and industrial process for producing semi-synthetic artemisinin utilized in the production of anti-malarial artemisinin-based combination therapies.
Just a few days ago, US President Barack Obama announced plans to withdraw most of the troops from West Africa after a 10-month long military mission to help contain the Ebola virus. The outbreak has been significantly contained from 1,000 new cases a week to roughly 150 a week. However, the fight is far from over.
What would happen if you got an infection and there was no effective antibiotic available to treat it?The World Health Organization (WHO) says this is no longer a “what if” scenario, it’s already happening in every region of the world.